Myocarditis cardiac transplantation

Myocarditis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology Adrenergic Myocarditis Giant Cell Myocarditis
Causes
Differentiating Myocarditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myocarditis cardiac transplantation On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Google Images
American Roentgen Ray Society Images of Myocarditis cardiac transplantation All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myocarditis cardiac transplantation
CDC on Myocarditis cardiac transplantation
Myocarditis cardiac transplantation in the news
Blogs on Myocarditis cardiac transplantation
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Myocarditis cardiac transplantation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Cardiac transplantation is sometimes required to treat refractory giant cell myocarditis. However, the condition can recur in post-transplant patients. Recurrence of biopsy proven giant cell myocarditis between 3 weeks to 9 years was observed in 9 of 34 cardiac transplant patients .